Effect of efflux on telithromycin and macrolide susceptibility in Haemophilus influenzae

被引:26
作者
Bogdanovich, T
Bozdogan, B
Appelbaum, PC
机构
[1] Milton S Hershey Med Ctr, Dept Pathol, Hershey, PA 17033 USA
[2] Adnan Menderes Univ, Tip Fak, Mikrobiyol & Klin Mikrobiyol AD, TR-09100 Aydin, Turkey
关键词
D O I
10.1128/AAC.50.3.893-898.2006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
This study investigated the presence of telithromycin and azithromycin efflux in 58 clinical strains of Haemophilus influenzae with various susceptibilities to macrolides, azalides, and ketolides. Efflux pumps were studied by measuring accumulation of radioactive [H-3] telithromycin and [N-methyl-H-3]azithromycin in the presence and absence of carbonyl m-chlorophenylhydrazone (CCCP), a protonophore. In 17 strains for which the telithromycin MICs were 0.06 to 0.5 mu g/ml (azithromycin MICs, <= 0.06 to 0.125 mu g/ml; clarithromycin MICs, <= 0.06 to 2 mu g/ml), telithromycin and azithromycin accumulations were high without CCCP and not affected by its addition, which indicates absence of efflux. In 22 strains for which the telithromycin MICs were 0.25 to 4 mu g/ml (azithromycin MICs, 0.25 to 1 mu g/ml; clarithromycin MICs, 1 to 8 mu g/ml), initially low levels of telithromycin accumulation became higher after addition of CCCP, indicating a functioning efflux pump. Nineteen strains for which the telithromycin MICs were >= 2 mu g/ml had efflux as well as various mutations in ribosomal proteins L4, L22, and/or 23S rRNA (domains II and V). Of these 19 strains, the telithromycin MICs ( >= 8 mu g/ml) for 17 of them were significantly raised (azithromycin, MICs 4 to > 32 mu g/ml; clarithromycin MICs, 8 to > 32 mu g/ml). From these results we conclude that telithromycin efflux with or without additional ribosomal alterations is present in all H. influenzae strains, except for those for which the telithromycin MICs were very low.
引用
收藏
页码:893 / 898
页数:6
相关论文
共 28 条
[1]   Community-acquired pneumonia in adults: Guidelines for management [J].
Bartlett, JG ;
Breiman, RF ;
Mandell, LA ;
File, TM .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (04) :811-838
[2]   EFFICACY AND TOLERABILITY OF AZITHROMYCIN VERSUS AMOXICILLIN/CLAVULANIC ACID IN ACUTE PURULENT EXACERBATION OF CHRONIC-BRONCHITIS [J].
BEGHI, G ;
BERNI, F ;
CARRATU, L ;
CASALINI, A ;
CONSIGLI, G ;
DANTO, M ;
GIOIA, V ;
MOLINO, A ;
PAIZIS, G ;
VAGHI, A .
JOURNAL OF CHEMOTHERAPY, 1995, 7 (02) :146-152
[3]   Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis [J].
Chodosh, S ;
Schreurs, A ;
Siami, G ;
Barkman, HW ;
Anzueto, A ;
Shan, M ;
Moesker, H ;
Stack, T ;
Kowalsky, S .
CLINICAL INFECTIOUS DISEASES, 1998, 27 (04) :730-738
[4]   The AcrAB-TolC pump is involved in macrolide resistance but not in telithromycin efflux in Enterobacter aerogenes and Escherichia coli [J].
Chollet, R ;
Chevalier, J ;
Bryskier, A ;
Pagés, JM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (09) :3621-3624
[5]   Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children [J].
Dagan, R ;
Leibovitz, E ;
Fliss, DM ;
Leiberman, A ;
Jacobs, MR ;
Craig, W ;
Yagupsky, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (01) :43-50
[6]   Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media [J].
Dagan, R ;
Johnson, CE ;
McLinn, S ;
Abughali, N ;
Feris, J ;
Leibovitz, E ;
Burch, DJ ;
Jacobs, MR .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (02) :95-104
[7]   EVALUATION OF THE MICROBIOLOGY OF CHRONIC ETHMOID SINUSITIS [J].
DOYLE, PW ;
WOODHAM, JD .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (11) :2396-2400
[8]   The macrolide-ketolide antibiotic binding site is formed by structures in domains II and V of 23S ribosomal RNA [J].
Hansen, LH ;
Mauvais, P ;
Douthwaite, S .
MOLECULAR MICROBIOLOGY, 1999, 31 (02) :623-631
[9]   Principles of appropriate antibiotic use for acute rhinosinusitis in adults: Background [J].
Hickner, JM ;
Bartlett, JG ;
Besser, RE ;
Gonzales, R ;
Hoffman, JR ;
Sande, MA .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (06) :498-505
[10]   Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters [J].
Jacobs, MR .
CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 (11) :589-596